Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.
Peyrin-Biroulet
Laurent
L
Bressenot
Aude
A
Chone
Laurence
L
Denjean
Philippe
P
Boissel
Patrick
P
Bigard
Marc-André
MA
Bronowicki
Jean-Pierre
JP
D000230:Adenocarcinoma / Q000139:chemically induced*; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D002430:Cecal Neoplasms / Q000139:chemically induced; D015209:Cholangitis, Sclerosing / Q000601:surgery*; D003110:Colonic Neoplasms / Q000139:chemically induced*; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D016031:Liver Transplantation; D008297:Male; D011183:Postoperative Complications
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab